Evidence map›Paper›PMID 33976153›Full record

ArticleNature communications2021

Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype.

Marija Kojic, Tomasz Gawda, Monika Gaik, Alexander Begg, Anna Salerno-Kochan, Nyoman D Kurniawan, Alun Jones, Katarzyna Drożdżyk, Anna Kościelniak, Andrzej Chramiec-Głąbik and 30 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. TRIAGE: an R package for regulatory gene analysis.Briefings in bioinformatics · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 12 institutions in 6 countries.

Marija KojicThe University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0001-6437-283X
Tomasz GawdaMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.ORCID http://orcid.org/0000-0001-7906-0097
Monika GaikMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Alexander BeggInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Anna Salerno-KochanMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Nyoman D KurniawanCentre for Advanced Imaging, The University of Queensland, Brisbane, QLD, Australia.
Alun JonesInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Katarzyna DrożdżykMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Anna KościelniakMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Andrzej Chramiec-GłąbikMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
Soroor Hediyeh-ZadehBioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-7513-6779
Maria KashermanSchool of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.
Woo Jun ShimInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0001-9446-7821
Enakshi SinniahInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0002-3403-3658
Laura A GenovesiThe University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia.
Rannvá K AbrahamsenDepartment of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.ORCID http://orcid.org/0000-0001-8742-783X
Christina D FengerDepartment of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.
Camilla G MadsenCentre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.
Julie S CohenDepartment of Neurology and Developmental Medicine, Division of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-1545-0293
Ali FatemiDepartment of Neurology and Developmental Medicine, Division of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-4116-6990
Zornitza StarkDepartment of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-8640-1371
Sebastian LunkeVictorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Joy LeeDepartment of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia.
Jonas K HansenDepartment of Paediatrics, Regional Hospital Viborg, Viborg, Denmark.
Martin F BoxillDepartment of Paediatrics, Regional Hospital Viborg, Viborg, Denmark.
Boris KerenDepartment of Genetics, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
Isabelle MareyDepartment of Genetics, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
Margarita S SaenzThe University of Colorado Anschutz, Children's Hospital Colorado, Aurora, CO, USA.
Kathleen BrownThe University of Colorado Anschutz, Children's Hospital Colorado, Aurora, CO, USA.
Suzanne A AlexanderQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
Sergey MureevCSIRO-QUT Synthetic Biology Alliance, Centre for Tropical Crops and Bio-commodities, Queensland University of Technology, Brisbane, QLD, Australia.
Alina BatzillaInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0003-3893-8355
Melissa J DavisBioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0003-4864-7033
Michael PiperSchool of Biomedical Sciences, The University of Queensland, Brisbane, QLD, Australia.
Mikael BodénSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0003-3548-268X
Thomas H J BurneQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0003-3502-9789
Nathan J PalpantInstitute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.ORCID http://orcid.org/0000-0002-9334-8107
Rikke S MøllerDepartment of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund, Denmark.
Sebastian GlattMalopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland. sebastian.glatt@uj.edu.pl.ORCID http://orcid.org/0000-0003-2815-7133
Brandon J WainwrightThe University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia. b.wainwright@uq.edu.au.ORCID http://orcid.org/0000-0003-0406-2092
The University of Queensland · AUJagiellonian University · PLThe University of Melbourne · AUTranslational Research Institute · AUChildren's Hospital Colorado · USKennedy Krieger Institute · USRegionshospitalet Viborg · DKSorbonne Université · FRCommonwealth Scientific and Industrial Research Organisation · AUHvidovre Hospital · DKRoyal Children's Hospital · AUUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intellectual disability (ID) and autism spectrum disorder (ASD) are the most common neurodevelopmental disorders and are characterized by substantial impairment in intellectual and adaptive functioning, with their genetic and molecular basis remaining largely unknown. Here, we identify biallelic variants in the gene encoding one of the Elongator complex subunits, ELP2, in patients with ID and ASD. Modelling the variants in mice recapitulates the patient features, with brain imaging and tractography analysis revealing microcephaly, loss of white matter tract integrity and an aberrant functional connectome. We show that the Elp2 mutations negatively impact the activity of the complex and its function in translation via tRNA modification. Further, we elucidate that the mutations perturb protein homeostasis leading to impaired neurogenesis, myelin loss and neurodegeneration. Collectively, our data demonstrate an unexpected role for tRNA modification in the pathogenesis of monogenic ID and ASD and define Elp2 as a key regulator of brain development.

Indexed as

MutationAnimalsAutism Spectrum DisorderDisease Models, AnimalEpigenesis, GeneticGroomingHumansIntellectual DisabilityIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMice, Inbred DBAMice, KnockoutNeurodevelopmental DisordersPhenotypeSf9 CellsELP2 protein, humanIntracellular Signaling Peptides and Proteins

Identifiers

PMID33976153
PMCPMC8113450
OpenAlexW3162847608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.